Collectively, these results demonstrate that olivomycin A suppresses renal cancer cell migration by modulating EMT-related proteins—downregulating Snail and N-cadherin while enhancing E-cadherin and ZO-1—thereby reinforcing epithelial characteristics and limiting invasive potential. The gene discussed is CDH2; the disease is renal carcinoma.